BOT:ASX
Botanix Pharmaceuticals Ltd
A$0.017
0.00%
(0.00) 1D
Okt 6, 4:10:29 PM GMT+11 · AUD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa BOT...
Buksan
A$0.02
Mataas
A$0.02
Mababa
A$0.02
Mkt. cap
39.90M
Avg. na dami
5.79M
Dami
10.42M
Mataas nang 52-wk
A$0.17
Mababa nang 52-wk
A$0.02
EPS
-A$0.03
Mga natitirang share
2.76B
Bilang ng mga empleyado
11
Buksan
A$0.02
Mataas
A$0.02
Mababa
A$0.02
Mkt. cap
39.90M
Avg. na dami
5.79M
Dami
10.42M
Mataas nang 52-wk
A$0.17
Mababa nang 52-wk
A$0.02
EPS
-A$0.03
Mga natitirang share
2.76B
Bilang ng mga empleyado
11
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Bloomberg.com
·
2 oras ang nakalipas
S&P 500 Set for First Record Since August as Bulls Downplay Risk
MarketWatch
·
4 araw ang nakalipas
The stock market is anything but normal right now — and these charts show it
Reuters
·
1 buwan ang nakalipas
S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
The Motley Fool
·
5 araw ang nakalipas
Will the Stock Market Crash? History Gives a 95% Reason to Stay Calm
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
Tungkol sa Botanix Pharmaceuticals Ltd